Cafepharma Today

September 6 2024 - FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
Edwards cuts more than 500 employees after critical care sale
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
What 3 layoff stories reveal about pharma’s troubles
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
Fierce Biotech
Friday, September 6, 2024 - 11:48am
tags:
Iterum, UTIs, FDA
Edwards cuts more than 500 employees after critical care sale
Medtech Dive
Friday, September 6, 2024 - 11:27am
tags:
Edwards Lifesciences, Medtech, layoffs
Fresh off first regulatory win, ImmunityBio hints at financial troubles
First Word Pharma
Friday, September 6, 2024 - 11:13am
tags:
ImmunityBio, layoffs, anktiva, bladder cancer
Despite trial scare, Travere's Filspari gains full FDA nod in kidney disease showdown with Novartis
Fierce Pharma
Friday, September 6, 2024 - 10:57am
tags:
Travere Therapeutics, FDA, Filspari, IgA nephropathy
Bicara Therapeutics aims for up to $828 mln valuation in U.S. IPO
Reuters
Friday, September 6, 2024 - 10:55am
tags:
Bicara Therapeutics, IPOs, cancer
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
Reuters
Friday, September 6, 2024 - 10:54am
tags:
Zenas BioPharma, IPOs, Bristol Myers Squibb, obexelimab
OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders
Businesswire
Friday, September 6, 2024 - 10:50am
tags:
OrsoBio, obesity, funding
Boehringer and CDR-Life report data from geographic atrophy treatment trial
Clinical Trials Arena
Friday, September 6, 2024 - 10:49am
tags:
Boehinger Ingelheim, CDR-Life, clinical trials, geographic atrophy, BI 771716
What 3 layoff stories reveal about pharma’s troubles
Pharma Voice
Friday, September 6, 2024 - 10:48am
tags:
layoffs, Bayer, Tome Biosciences, Biomarin
GSK says Nucala hits the target in new COPD trial
Pharmaphorum
Friday, September 6, 2024 - 10:46am
tags:
GSK, COPD, Nucala, clinical trials
Lykos CEO to depart after FDA rejection, layoffs
BioPharma Dive
Thursday, September 5, 2024 - 10:38pm
tags:
Lykos Therapeutics, Pharma CEOs, FDA, MDMA, Amy Emerson
Astellas unveils Massachusetts lab that will be shared with biotechs, academia researchers
Fierce Biotech
Thursday, September 5, 2024 - 10:37pm
tags:
Astellas, Massachusetts, biotech, SakuLab, R&D
Purdue Pharma gets extension for Sackler settlement talks
Reuters
Thursday, September 5, 2024 - 10:33pm
tags:
Purdue Pharma, legal, Sackler family, opioids, opioid crisis
Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025
Managed Healthcare Executive
Thursday, September 5, 2024 - 10:32pm
tags:
Evernorth Health, Stelara, biosimilars, Janssen, JNJ
BIOSECURE Act heads for possible vote in House of Representatives next week
Fierce Pharma
Thursday, September 5, 2024 - 10:30pm
tags:
legislation, biotech, Biosecure Act, China
57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65
Forbes
Thursday, September 5, 2024 - 10:29pm
tags:
obesity, GLP-1, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, insurers
Glenmark joins growing list of drugmakers to settle long-running US price-fixing claims
Fierce Pharma
Thursday, September 5, 2024 - 10:27pm
tags:
Glenmark, legal, price fixing
Eli Lilly says experimental insulin could mean 313 fewer injections per year
Quartz
Thursday, September 5, 2024 - 11:50am
tags:
Eli Lilly, long-acting insulin, diabetes, clinical trials, efsitora
Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases
BioSpace
Thursday, September 5, 2024 - 11:40am
tags:
Amgen, obesity, MariTide, Medicare
Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Reuters
Thursday, September 5, 2024 - 11:38am
tags:
Eli Lilly, Genetic Leap, drug development, artificial intelligence

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble?
Drug Channels
The Healthcare Innovation Company's Value-Based Care Summit
Drug Channels
Embedding Into the Provider’s Workflow is Key to a Specialty Drug’s Success
Drug Channels
Drug Channels News Roundup, August 2024: My $0.02 on the IRA’s MFPs, UNC’s New PBM, Amazon vs. Retail, Fixing 340B, and Mark Cuban Lets Loose
Drug Channels
When Payers Become Producers: Inside the PBM Private-Labeling Trend
Drug Channels
Can Rite Aid Recover?
Drug Channels
IRA Reality Check: Four Strategies for Adapting Hub and Copay Programs
Drug Channels
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)
Drug Channels
Mid-Year Hub Review: Five Considerations for Staying Ahead of the Curve
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Los Angeles W, CA
Los Angeles, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago, IL
Chicago, Illinois,
Otsuka
Sales Representative - Paid Training
Caldwell, Idaho, 83607
Bartlett Roofing
Pharmaceutical Sales Customer Engagement- Poughkeepsie, NY
Poughkeepsie, New York,
Otsuka
Medical Device Sales Specialist
Durham, North Carolina
B. Braun Medical Inc
Pharmaceutical Sales Customer Engagement - Parkersburg, WV
West Virginia, West Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement- Baltimore South
Baltimore, Maryland,
Otsuka
Pharmaceutical Sales Customer Engagement - Hinsdale, IL
Illinois, Illinois,
Otsuka
Regional Sales Manager - Central Texas
Dripping Springs, Texas, 78620
Clinical Pathology Laboratories, Inc
Regional Sales Manager - Central Texas
Georgetown, Texas, 78628
Clinical Pathology Laboratories, Inc
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information